Park Ha Biological Technology Co., Ltd. (BYAH) — Capital Reinvestment Ratio
Park Ha Biological Technology Co., Ltd. (BYAH) has a Capital Reinvestment Ratio of 0.09x as of October 2024, meaning it reinvests 0% of its operating cash flow ($960.47K) in capital expenditures ($85.57K). See BYAH equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Park Ha Biological Technology Co., Ltd. Capital Reinvestment Ratio (2022–2024)
This chart tracks Park Ha Biological Technology Co., Ltd.'s Capital Reinvestment Ratio across 3 annual periods. Check total reinvestment intensity of Park Ha Biological Technology Co., Ltd. to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Park Ha Biological Technology Co., Ltd. (2022–2024)
Year-by-year Capital Reinvestment Ratio for Park Ha Biological Technology Co., Ltd. from 2022 to 2024. For live market cap and broader valuation context, see BYAH market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | $960.47K | $85.57K | ▼ -50.3% |
| 2023 | 0.18x | $126.54K | $22.68K | ▲ +2073.8% |
| 2022 | 0.01x | $1.44 Million | $11.89K | — |